Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Global, Regional and National Burden of Cancers Attributable to High Fasting Plasma Glucose in 204 Countries and Territories, 1990-2019
Saeid Safiri, Seyed Aria Nejadghaderi, Nahid Karamzad, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Safety and Preliminary Efficacy of Mesenchymal Stromal Cell (ORBCEL-M) Therapy in Diabetic Kidney Disease: A Randomized Clinical Trial (NEPHSTROM)
Norberto Perico, Giuseppe Remuzzi, Matthew D. Griffin, et al.
Journal of the American Society of Nephrology (2023) Vol. 34, Iss. 10, pp. 1733-1751
Open Access | Times Cited: 30
Global burden of pancreatic cancer attributable to metabolic risks from 1990 to 2019, with projections of mortality to 2030
Ru He, Wenkai Jiang, Chenyu Wang, et al.
BMC Public Health (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 13
Global burden of colorectal cancer attributable to metabolic risks from 1990 to 2021, with predictions to 2046
Xiaoyue Zhang, Ziqing Xu, Lin Shang, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Global burden, trends and inequalities for ischaemic heart disease attributable to high fasting plasma glucose, high low‐density lipoprotein cholesterol and high systolic blood pressure, 1990–2021: An analysis of the Global Burden of Disease Study 2021
Jeung Hee An, Yumeng Jia, Xiulin Shi, et al.
Diabetes Obesity and Metabolism (2025)
Closed Access | Times Cited: 1
Estimates and trends of the global burden of NASH-related liver cancer attributable to high fasting plasma glucose in 1990–2019: analysis of data from the 2019 Global Burden of Disease Study
Ziyi Li, Na Yang, Liyun He, et al.
Diabetology & Metabolic Syndrome (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 12
Global burden of common cancers attributable to metabolic risks from 1990 to 2019
Qing‐Qing Xing, Jing-Mao Li, Zhijian Chen, et al.
Med (2023) Vol. 4, Iss. 3, pp. 168-181.e3
Open Access | Times Cited: 12
Impact of social and economic factors on global thyroid cancer incidence and mortality
Yi‐Chiung Hsu, Sheena Yi-Hsin Cheng, Ming-Nan Chien, et al.
European Archives of Oto-Rhino-Laryngology (2023) Vol. 280, Iss. 9, pp. 4185-4193
Closed Access | Times Cited: 11
Cancer burden attributable to risk factors, 1990–2019: A comparative risk assessment
Junjie Hu, Hongliang Dong, Yiming Dong, et al.
iScience (2024) Vol. 27, Iss. 4, pp. 109430-109430
Open Access | Times Cited: 4
Trends and projection of burden on lung cancer and risk factors in China from 1990 to 2060
Baozhen He, Xingyu Zhao, Yang Pu, et al.
Thoracic Cancer (2024) Vol. 15, Iss. 22, pp. 1688-1704
Open Access | Times Cited: 4
Global burden of colorectal cancer attributable to metabolic risks from 1990 to 2021, with projections of mortality to 2035
Mingming He, Ruru Gu, Xin Huang, et al.
International Journal of Colorectal Disease (2025) Vol. 40, Iss. 1
Open Access
Pancreatic cancer mortality trends attributable to high fasting blood sugar over the period 1990–2019 and projections up to 2040
Yongguang Wei, Zedong Qin, Xiwen Liao, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 3
Global, regional, and national time trends in cancer mortality attributable to high fasting plasma glucose: an age-period cohort analysis
Jing Xie, Zeye Liu, Liqun Ren, et al.
BMC Public Health (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 8
Global and regional estimates of tuberculosis burden attributed to high fasting plasma glucose from 1990 to 2019: emphasis on earlier glycemic control
Qin Bian, Yanjun Zhang, Chen Xue, et al.
BMC Public Health (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Estimates of bladder cancer burden attributable to high fasting plasma glucose: Findings of the Global Burden of Disease Study 2019
Ying Wu, Yujiao Deng, Zhijun Dai, et al.
Cancer Medicine (2023) Vol. 12, Iss. 15, pp. 16469-16481
Open Access | Times Cited: 5
Temporal trends in mortality of tuberculosis attributable to high fasting plasma glucose in China from 1990 to 2019: a joinpoint regression and age-period-cohort analysis
Chao Wang, Xueli Yang, Honglu Zhang, et al.
Frontiers in Public Health (2023) Vol. 11
Open Access | Times Cited: 4
Beating Cancer Inequalities in the EU

OECD health policy studies (2024)
Open Access | Times Cited: 1
Burden of liver cancer attributable to high fasting plasma glucose: a global analysis based on the global burden of disease study 2019
Minmin Wang, Jingyi Liu, Yan Liang, et al.
The journal of nutrition health & aging (2024) Vol. 28, Iss. 6, pp. 100261-100261
Open Access | Times Cited: 1
Trend and forecast analysis of the changing disease burden of pancreatic cancer attributable to high fasting glucose in China, 1990–2021
Lichen Song, Ziyi Chen, Yongjie Li, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Global estimates of rehabilitation needs and disease burden in tracheal, bronchus, and lung cancer from 1990 to 2019 and projections to 2045 based on the global burden of disease study 2019
Xigui Lai, Conghui Li, Yao Yang, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 3
Global, regional, and national burden of tracheal, bronchus, and lung cancers attributable to high fasting plasma glucose: A systematic analysis of global burden of disease 2019
Minmin Wang, Jingyi Liu, Jia Wang, et al.
Journal of Diabetes (2023) Vol. 16, Iss. 3
Open Access | Times Cited: 3
The predictions of seven cancers burden attributed to high fasting plasma glucose from 2020 to 2030
Jianming Ye, Ping Wang, Juan‐Juan Qin, et al.
Research Square (Research Square) (2024)
Open Access
Povzetek

OECD health policy studies (2024)
Open Access
Résumé

OECD health policy studies (2024)
Open Access
Executive summary

OECD health policy studies (2024)
Open Access
Pharmacokinetics and safety of pirfenidone in individuals with chronic kidney disease (CKD) stage G2 and G3a: a single-dose, Phase I, Bridging study
Dandan Yu, Rui Zhang, Jinping Zhou, et al.
Journal of Pharmaceutical Sciences (2024)
Closed Access
Page 1 - Next Page

Scroll to top